Nightingale Health receives regulatory approval for healthcare use from Health Sciences Authority in Singapore
Press release, 23 February 2024 at 9:00 a.m. (EET)
Nightingale Health, a pioneer in health risk detection and preventative health, has received regulatory approval from Singapore’s Health Sciences Authority (HSA), the national body that regulates medical devices, therapeutics, and other healthcare products. This first approval covers the analysis of eight common clinically used biomarkers: total cholesterol, HDL cholesterol, LDL cholesterol, triglycerides, apolipoprotein A1, apolipoprotein B, glucose, and creatinine.
Nightingale Health announced in November 2023 a collaboration